GeNO's Series D Round

GeNO raised a round of funding on October 18, 2013. Investors include SFW Capital Partners.

GeNO is a privately-held biopharmaceutical company focused on the design, development and commercialization of next-generation products to address unmet medical needs of patients with a variety of pul…

Articles about GeNO's Series D Round: